Australia's 'first for-benefit pharmeutical company'

That means, it says, its sole purpose is to distribute 100 per cent of its profits to local patient-support and medical-research organisations.
The focus of FBM is on the consumer of medications -- at this stage, medications sourced by FBM to treat breast cancer.
The medications sold by FBM are generic versions of two frontline breast-cancer treatments, newly available through a prescription from a doctor.
All of the profits go to supporting two services, Breast Cancer Network Australia and the Breast Cancer Institute of Australia.
FBM director John Hurley explains how the company works.

"FBM works on the basis of a full-blown pharmaceutical company. We source product from overseas. We sell the product through distribution chains, et cetera, the same as other pharmaceutical companies. The only difference -- well, the major difference -- is that we give a hundred per cent of the profits we generate back to patient support and research in Australia."

Mr Hurley has witnessed firsthand the effects of chronic diseases, including breast and bowel cancer, Type 2 diabetes and Alzheimer's disease, on family members and friends.
He felt, after having such a successful career, it was time for him to give something back.

"It's one of those things that you can say, 'I've really done something in my life.' I have a strong belief that, if you're given an opportunity to do something like this, you kind of like have to do it. If you have the opportunity to help people like this, for people who can't help themselves, you should actually go and do that type of thing."

Read More..